Gösterge TablosuPortföylerİzleme ListesiToplulukKeşfedinScreener
NOT FOR DISTRIBUTION

Stepan Company

NYSE:SCL Stok Raporu

Piyasa değeri: US$1.4b

  • Şirkete Genel Bakış
  • Değerleme
  • Gelecekteki Büyüme
  • Geçmiş Performans
  • Finansal Sağlık
  • Temettü
  • Yönetim
  • Sahiplik
  • Diğer Bilgiler
  • Hisse Senedi Topluluğu

Stepan Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Stepan şirketinin kazançları yıllık ortalama -39.2% oranında azalırken, Chemicals sektörünün kazançları yıllık 2.9% oranında azalan oldu. Gelirler yıllık ortalama 1.5% oranında azalan oldu.

Anahtar bilgiler

-39.15%

Kazanç büyüme oranı

-39.07%

EPS büyüme oranı

Chemicals Sektör Büyümesi12.93%
Gelir büyüme oranı-1.50%
Özkaynak getirisi-0.22%
Net Marj-0.11%
Son Kazanç Güncellemesi30 Jun 2026

Yakın geçmiş performans güncellemeleri

Recent updates

Analiz Makalesi • Aug 08

Results: Stepan Company Beat Earnings Expectations And Analysts Now Have New Forecasts

Stepan Company ( NYSE:SCL ) defied analyst predictions to release its second-quarter results, which were ahead of...
User avatar
Anlatı Güncellemesi • Aug 07

SCL: Higher Margin Assumptions Will Support Long-Term Dividend Upside

Analysts have raised their price target for Stepan from $75 to $85, citing updated assumptions that include a lower discount rate, an increased profit margin of 10.80%, and a more conservative future P/E of 8.05x. What’s in the News for Stepan Stepan Company was added to the Russell 2000 Dynamic Index as an index constituent.
Seeking Alpha • Jul 10

Stepan Company's Discount Isn't Over Yet

Summary Stepan Company remains a 'buy' due to attractive valuation, despite recent underperformance versus the S&P 500. Recent results show mixed fundamentals: revenue growth driven by Surfactants, but profitability pressured by restructuring charges and raw material costs. Project Catalyst targets $100 million in pre-tax cost savings over two years, with 60% expected this year and the remainder next. SCL’s strategy focuses on expanding share in large, growing addressable markets across Surfactants and Polymers, supporting long-term upside. Read the full article on Seeking Alpha
User avatar
Anlatı Güncellemesi • Jun 18

SCL: Stable Margins And Outlook Will Support Long-Term Dividend Upside

Analysts have kept their Stepan price target steady at $75, citing largely unchanged assumptions for fair value, discount rate, revenue growth, profit margin, and future P/E as the basis for this reaffirmed view. What’s in the News for Stepan No recent Stepan news items were identified in the provided primary news source.
User avatar
Anlatı Güncellemesi • Jun 04

SCL: Higher Margins And Revenue Outlook Will Support Long-Term Dividend Upside

Analysts have raised their price target for Stepan to $75.00, with the shift supported by updated assumptions for slightly lower discount rates, expectations of higher revenue, stronger profit margins, and a reduced future P/E multiple. What's in the News No recent company specific news items, periodical coverage, or key developments were provided for Stepan in the supplied sources.
User avatar
Anlatı Güncellemesi • Apr 28

SCL: Stable Margins And Buybacks Will Support Long-Term Dividend Upside

Analysts kept their fair value estimate steady at $75, with only marginal tweaks to the discount rate, revenue growth, profit margin, and future P/E assumptions. This indicates a largely unchanged view of Stepan's longer term potential.
User avatar
Anlatı Güncellemesi • Apr 12

SCL: Stable Margins And Buyback Completion Will Support Long-Term Dividend Upside

Analysts have nudged their Stepan price target slightly higher to $75.00, with modest tweaks to the discount rate and P/E assumptions supporting this updated view. What's in the News For the three months ended December 31, 2025, Stepan Company reported unaudited goodwill impairment of $6,245,000, which directly affects reported earnings quality for that period (Key Developments).
User avatar
Anlatı Güncellemesi • Mar 28

SCL: Steady Fair Value And Margins Will Support Long-Term Dividend Upside

Analysts have maintained their Stepan fair value estimate at $75.00, making only small adjustments to the discount rate, revenue growth, profit margin and future P/E assumptions. This signals that their overall view on the stock’s longer-term potential remains largely unchanged.
User avatar
Anlatı Güncellemesi • Mar 14

SCL: Steady Fair Value And Margins Will Support Long-Term Dividend Upside

Analysts have modestly revised their price outlook for Stepan, keeping fair value around $75.00 while making small tweaks to the discount rate and projected P/E. This reflects updated assumptions about the risk profile and valuation multiples rather than a shift in the underlying growth or margin view.
User avatar
Anlatı Güncellemesi • Feb 27

SCL: Higher Future P/E Assumptions Will Support Long-Term Dividend Upside

Analysts have adjusted their Stepan price target to $75.00, with the change tied to updated views on discount rate, revenue growth, profit margin, and a higher assumed future P/E multiple. What's in the News Stepan Company reported an unaudited goodwill impairment of $6,245,000 for the three months ended December 31, 2025.
User avatar
Anlatı Güncellemesi • Feb 11

SCL: Refined Discount Rate Assumptions Will Support Long-Term Dividend Upside

Analysts have kept their Stepan price target steady at $75.00, citing only slight tweaks to assumptions like discount rate, revenue growth, profit margin, and future P/E that were not material enough to change their overall valuation view. Valuation Changes Fair Value: Steady at $75.00, indicating no change in the analysts' central valuation estimate.
Analiz Makalesi • Feb 04

Why Investors Shouldn't Be Surprised By Stepan Company's (NYSE:SCL) 26% Share Price Surge

Despite an already strong run, Stepan Company ( NYSE:SCL ) shares have been powering on, with a gain of 26% in the last...
User avatar
Anlatı Güncellemesi • Jan 27

SCL: Higher Discount Rate Will Set Up Attractive Long-Term Dividend Returns

Analysts now estimate Stepan's fair value at US$75.00, reduced from US$82.21. This change reflects updated assumptions regarding a higher discount rate, revised profit margin expectations, a slightly higher revenue growth outlook, and a lower future P/E multiple.
Analiz Makalesi • Jan 08

Stepan (NYSE:SCL) May Have Issues Allocating Its Capital

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Amongst other things...
Analiz Makalesi • Dec 12

Why Stepan Company (NYSE:SCL) Could Be Worth Watching

Stepan Company ( NYSE:SCL ), is not the largest company out there, but it saw a double-digit share price rise of over...
Analiz Makalesi • Nov 04

Stepan (NYSE:SCL) Will Pay A Larger Dividend Than Last Year At $0.395

Stepan Company's ( NYSE:SCL ) periodic dividend will be increasing on the 15th of December to $0.395, with investors...
Analiz Makalesi • Sep 04

Here's What's Concerning About Stepan's (NYSE:SCL) Returns On Capital

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...
Analiz Makalesi • Jul 31

Is It Time To Consider Buying Stepan Company (NYSE:SCL)?

While Stepan Company ( NYSE:SCL ) might not have the largest market cap around , it received a lot of attention from a...
Analiz Makalesi • Jun 10

Earnings Tell The Story For Stepan Company (NYSE:SCL)

Stepan Company's ( NYSE:SCL ) price-to-earnings (or "P/E") ratio of 22.5x might make it look like a sell right now...
Analiz Makalesi • May 02

Results: Stepan Company Exceeded Expectations And The Consensus Has Updated Its Estimates

A week ago, Stepan Company ( NYSE:SCL ) came out with a strong set of first-quarter numbers that could potentially lead...
Seeking Alpha • Apr 20

Stepan Company's Plunge Offers Investors A Chance To Clean Up

Summary Markets are inefficient short-term, creating opportunities for logical, value-oriented investors; Stepan Company is now a ‘buy’ due to recent price drops and management's positive outlook. Despite a 6% revenue drop in 2024, Stepan Company improved net income and EBITDA, driven by cost-cutting measures and productivity improvements. Management is optimistic about 2025, expecting volume growth, margin improvement, and positive free cash flow, targeting high-margin, growth-oriented markets. Analysts forecast revenue and earnings growth for Q1 2025; shares are attractively priced compared to peers, justifying an upgrade to a ‘buy’ rating. Read the full article on Seeking Alpha
Analiz Makalesi • Apr 16

Should You Investigate Stepan Company (NYSE:SCL) At US$47.60?

While Stepan Company ( NYSE:SCL ) might not have the largest market cap around , it received a lot of attention from a...
Seeking Alpha • Feb 04

Stepan Company: A 'Moderate Buy' Despite A High Valuation

Summary Stepan Company, a specialty chemicals manufacturer, excels in operational efficiency and dividend growth, making it a stable investment despite current valuations. Q3 FY24 financials show margin expansion and significant net income growth, despite a 3% revenue decline, highlighting fiscal discipline. Trading at a forward P/E of 17.3x for 2025, Stepan's stock has a potential 26% upside, making it a promising investment opportunity. I am an investment analyst with a focus on income generation. Read the full article on Seeking Alpha
Analiz Makalesi • Jan 18

Shareholders Should Be Pleased With Stepan Company's (NYSE:SCL) Price

With a price-to-earnings (or "P/E") ratio of 31.4x Stepan Company ( NYSE:SCL ) may be sending very bearish signals at...
Analiz Makalesi • Nov 26

These 4 Measures Indicate That Stepan (NYSE:SCL) Is Using Debt Extensively

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analiz Makalesi • Nov 02

Stepan's (NYSE:SCL) Upcoming Dividend Will Be Larger Than Last Year's

The board of Stepan Company ( NYSE:SCL ) has announced that the dividend on 13th of December will be increased to...
Seeking Alpha • Oct 30

Stepan Company: Not A Great Performance, But Good Value

Summary Stepan Company, despite underperformance and volatility, has long-term upside due to its unique position in the specialty chemicals market, particularly surfactants. The company's fundamentals have improved with reduced CapEx and positive FCF, but current earnings and macro pressures persist. SCL's growth potential is tied to the surfactant segment and market diversification, though the timing of earnings recovery remains uncertain. I rate Stepan as a "Buy" with a $90 PT, but caution that there are superior investments in the chemicals sector with better returns. Read the full article on Seeking Alpha

Gelir ve Gider Dağılımı

Stepan nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

NYSE:SCL Gelir, gider ve kazançlar (USD Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 262,433-314562
31 Mar 262,343-1414360
31 Dec 252,3324714259
30 Sep 252,3044514257
30 Jun 252,2605814557
31 Mar 252,2225614256
31 Dec 242,1805014556
30 Sep 242,1874615357
30 Jun 242,2023514758
31 Mar 242,2263814458
31 Dec 232,3264014659
30 Sep 232,4215214260
30 Jun 232,5787915763
31 Mar 232,74911815965
31 Dec 222,77314715167
30 Sep 222,75615315567
30 Jun 222,64015114466
31 Mar 222,48414214864
31 Dec 212,34613815963
30 Sep 212,23115116362
30 Jun 212,09214716861
31 Mar 211,95814016859
31 Dec 201,87012715458
30 Sep 201,82011814656
30 Jun 201,80711114256
31 Mar 201,82010613955
31 Dec 191,85910315555
30 Sep 191,88010514153
30 Jun 191,93710114654
31 Mar 191,98410413954
31 Dec 181,99411113454
30 Sep 182,0019714355
30 Jun 181,9819713453
31 Mar 181,9569214054
31 Dec 171,92510113654
30 Sep 171,8729013954
30 Jun 171,8299014756
31 Mar 171,7899014656
31 Dec 161,7668615056
30 Sep 161,7659115156
30 Jun 161,7649413754
31 Mar 161,7628314152
31 Dec 151,7767613850
30 Sep 151,8116912347

Kaliteli Kazançlar: SCL şu anda kârlı değil.

Büyüyen Kar Marjı: SCL şu anda kârlı değil.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: SCL kârlı değildir ve zararlar son 5 yılda yılda 39.2% oranında artmıştır.

Büyüme Hızlandırma: SCL 'un son bir yıldaki kazanç büyümesinin 5 yıllık ortalamasıyla karşılaştırılması mümkün değil çünkü şu anda kârlı değil

Kazançlar vs. Sektör: SCL kârlı olmadığından, geçmiş yıl kazanç büyümesinin Chemicals sektörüyle ( 2.4% ) karşılaştırılması zorlaşıyor.


Özkaynak Getirisi

Yüksek ROE: SCL hissesi şu anda kârlı olmadığından negatif Özsermaye Getirisi'ne ( -0.22% ) sahiptir.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y

Şirket Analizi ve Finansal Veri Durumu

VeriSon Güncelleme (UTC saati)
Şirket Analizi2026/09/10 10:35
Gün Sonu Hisse Fiyatı2026/09/10 00:00
Kazançlar2026/06/30
Yıllık Kazançlar2025/12/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

PaketVeriZaman ÇerçevesiÖrnek ABD Kaynağı *
Şirket Finansalları10 yıl
  • Gelir tablosu
  • Nakit akış tablosu
  • Bilanço
  • SEC Form 10-K
  • SEC Form 10-Q
Analist Konsensüs Tahminleri+3 yıl
  • Finansal tahminler
  • Analist fiyat hedefleri
  • Analist Araştırma Raporları
  • Blue Matrix
Piyasa Fiyatları30 yıl
  • Hisse senedi fiyatları
  • Temettüler, Bölünmeler ve Eylemler
  • ICE Piyasa Verileri
  • SEC Form S-1
Sahiplik10 yıl
  • En büyük hissedarlar
  • İçeriden öğrenenlerin ticareti
  • SEC Form 4
  • SEC Form 13D
Yönetim10 yıl
  • Liderlik ekibi
  • Yönetim Kurulu
  • SEC Form 10-K
  • SEC Form DEF 14A
Önemli Gelişmeler10 yıl
  • Şirket duyuruları
  • SEC Form 8-K

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına Github sayfamızdan ulaşabilirsiniz; ayrıca raporlarımızı nasıl kullanacağınıza dair kılavuzlarımız ve YouTube’da eğitim videolarımız da bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

Stepan Company 4 Bu analistlerden 2, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

AnalistKurum
Michael HarrisonSeaport Research Partners
Daniel RizzoSidoti & Company, LLC
Vincent AndersonStifel, Equities Research

Her Yerde Daha İyi Yatırım Kararları Alın

İndirmek için tarayın
AppStore’u AçGoogle Play’i Aç
Chrome Web Mağazası
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
Veri Kaynaklarını Görüntüle
Piyasalar
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Yatırım Fikirleri
  • Değeri Düşük Şirketler
  • Temettü Santralleri
  • İçeriden Satın Alma
  • Nükleer Enerji
  • Otonom Araçlar
  • Yapay Zeka
  • Kripto ve Blok Zinciri
  • Siber güvenlik
  • Daha fazla fikir
Hisse Toplulukları
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Araçlar ve özellikler
  • Portföy Takibi
  • Hisse Senedi Tarayıcı & Uyarılar
  • Anlatılar ve Adil Değerler
  • Temettü Hesaplayıcı
Haberler ve Keşifler
  • Son Hisse Senedi Haberleri
  • Küresel Pazar İçgörüleri
  • Foxhole
  • Yatırım Fikirleri
  • Topluluk Anlatıları
  • Yenilikler
Simply Wall St
  • Planlar & Fiyatlandırma
  • Reklam
  • Hakkımızda
  • Bize Ulaşın
  • Kariyer
  • Yardım Merkezi
  • Hisse Senedi Yatırımını Öğrenin
  • Ortaklık Programı
  • İşletme ve Kurumsal
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Şartlar ve Koşullar
  • Gizlilik Politikası
  • Yapay Zeka Koşulları
  • Finansal Hizmetler Rehberi